Vaccine Stocks Rally on Speculation of Contract Awards After Russia Lab Incident
Novavax (NVAX), Moderna (MRNA), Emergent BioSolutions (EBS) and Arcturus Therapeutics (ARCT) advanced after a death at a Russian plague research institute. Retail investors speculated about potential federal contract awards.
A Russian lab worker’s unexplained death in a plague research institute lifted vaccine and biodefense shares on Monday, with Novavax (NVAX), Moderna (MRNA), Emergent BioSolutions (EBS) and Arcturus Therapeutics (ARCT) advancing as retail investors speculated about federal contracts.